... it based its decision on medical studies of OxyContin, reports of abuse and misuse, public comments and petitions. Stamford, Connecticut-based Purdue said in a statement that the new labeling will provide "important information to health care ...
via Stamford Newswire http://www.cbc.ca/news/health/story/2013/04/17/oxycontin-generic-tamper-fda.html?cmp=rss
via Stamford Newswire http://www.cbc.ca/news/health/story/2013/04/17/oxycontin-generic-tamper-fda.html?cmp=rss
No comments:
Post a Comment